Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $348.13 | 7 | 98.6% |
| Education | $5.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $207.49 | 3 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $112.32 | 2 | $0 (2017) |
| Takeda Pharmaceuticals America, Inc. | $33.32 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $353.13 | 8 | AstraZeneca Pharmaceuticals LP ($207.49) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $9.37 | General |
| Category: Central Nervous System (CNS) | ||||||
| 10/25/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $5.53 | General |
| Category: Central Nervous System (CNS) | ||||||
| 09/15/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $5.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/25/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Central Nervous System (CNS) | ||||||
| 07/07/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $110.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/28/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.24 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/09/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
About Dr. Larry Voelker, D.O
Dr. Larry Voelker, D.O is a Neuromusculoskeletal Medicine & OMM healthcare provider based in Cave Creek, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033215611.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Voelker, D.O has received a total of $353.13 in payments from pharmaceutical and medical device companies, with $353.13 received in 2017. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($348.13).
Practice Information
- Specialty Neuromusculoskeletal Medicine & OMM
- Other Specialties Family Medicine
- Location Cave Creek, AZ
- Active Since 09/15/2006
- Last Updated 04/23/2018
- Taxonomy Code 204D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033215611
Products in Payments
- FARXIGA (Drug) $207.49
- INVOKANA (Drug) $112.32
- Trintellix (Drug) $33.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.